Propofol Patient-controlled Sedation for Endoscopic Retrograde Cholangiopancreatography

• Status: Completed
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Propofol sedation with opioids is used for endoscopic retrograde cholangiopancreatography (ERCP). Combination of sedatives and opioids is associated with increased morbidity/mortality. Delivery of only propofol using a patient-controlled delivery system (patient-controlled sedation, PCS) could be an alternative for this purpose. Comparative studies with PCS for ERCP are few. Therefore, the main objective of this randomized controlled trial was to compare propofol PCS to sedation managed by nurse anaesthetists during ERCP.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lena Nilsson; University Hospital, Linkoeping
• Treatments: Propofol

Criteria

Inclusion Criteria:

• Need for ERCP

• Able to speak and read swedish

Exclusion Criteria:

• Allergy to propofol

• Severe cardiopulmonary disease (ASA IV)

• Confusion or dementia